Ikarian Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Ikarian Capital's VRTX Position: Q3 2022 in Review
Ikarian Capital sold out of Vertex Pharmaceuticals (VRTX) in Q3 2022, closing a stake of 40,000 shares — an estimated $11.3M sold.
Ikarian Capital first reported a position in VRTX in Q1 2022 and held it in 2 quarters. The position peaked at $11.3M in Q2 2022. 1,124 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.
- Ikarian Capital reported no remaining Vertex Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Ikarian Capital sold 40,000 Vertex Pharmaceuticals shares in Q3 2022, an estimated $11.3M.
- Ikarian Capital first reported a position in Vertex Pharmaceuticals in Q1 2022 and held it in 2 quarters.
- Ikarian Capital's Vertex Pharmaceuticals position peaked at $11.3M in Q2 2022.
- 1,124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.
Based on Ikarian Capital's 13F filing for Q3 2022, filed 14 Nov 2022.